Thus, we revealed that the circMET/snail/ DPP4/CXCL10 axis is a vital mechanism in HCC immunosuppression, and identified a subgroup of patients who can benefit from sitagliptin administration. This evidence concerns the gene DPP4 and hepatocellular carcinoma.